CIDP’CRO Enters into Asia-Pacific Region with Inauguration of Subsidiary in Singapore from Specialchem

4 February 2016

Published on 2016-02-02. Author : SpecialChem

SINGAPORE — CIDP, Centre International de Développement Pharmaceutique, a Mauritius-based private and independent Contract Research Organization (CRO), inaugurates its new Asia subsidiary in Singapore. This marks the Group’s first foray into the Asia-Pacific region, and is its fourth subsidiary after the ones located in Romania, India, and Brazil.

“We felt the need to expand internationally in order to broaden our services and diversify our skills”,

said Jean-Louis Roule, French CEO of CIDP.

“This fueled our decision to set up a new subsidiary in Asia, a region we are keen to serve due to its increasing economic importance. Singapore was a logical choice for our Asia office because of its excellent infrastructure, transparency of requirements and regulations, and convenient access to Asian markets. We are confident that this new venture will bring CIDP to greater heights.”

CIDP is a pioneer international group that specializes in research and development activities for pharmaceutical, medical device, nutrition, and cosmetic industries. With more than 15 years of experience, CIDP is a leading company in the field offering extensive scientific expertise in the dermo-cosmetics sector. The CIDP group comprises a strong team of highly qualified and experienced professionals, such as doctors, pharmacists, clinical research/trial assistants and managers, biostatisticians, and data managers. CIPD’s scientific know-how covers various aspects of drug discovery, and services offered include the evaluation of ingredients, raw materials, as well as drugs or cosmetics products.

CIDP’s Singapore subsidiary was officially unveiled in a ceremony held on 27 January. The opening was officiated by Claire Blazy-Jauzac, Group Managing Director of CIDP, and was attended by around 50 guests, including clients, business partners, embassy, and association representatives, etc. Located in Biopolis, an international research and development hub for biomedical sciences, the fully operational center is equipped with the latest technologies, and its investiture will enable CIDP to enhance its expertise in dermatology and cosmetics activities, and facilitate the development of new partnerships in R&D across the region.

Matsuoka Nobuaki, Vice-President of the Society of Cosmetics Scientists Singapore and Principle Scientist at Procter & Gamble Singapore commented,

“It’s a good thing to have more CROs in Singapore catering to local and regional companies that seek professional services for their development projects. I think CIDP’s presence in Singapore will help the industry, both for large laboratories that will benefit from the CIDP’s expertise in dermatology and cosmetics for their clinical research projects, and for start-ups who fully outsource their in vitro or in vivo testing needs. I would like to congratulate CIDP on their expansion and I Iook forward to more fruitful collaborations and new developments within the industry from Singapore and beyond.”

The Cosmetics Testing News